Factors Predicting Nodal Metastasis in Penile Cancer: Analysis from a Tertiary Center.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2022
Historique:
received: 09 05 2021
accepted: 20 09 2021
pubmed: 25 11 2021
medline: 9 7 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

Lymph node metastasis is an important prognostic marker in penile cancer. Identification of occult metastasis is by lymphadenectomy based on the histological features of primary tumor; however, this leads to unnecessary surgical morbidity in node negative patients. A retrospective analysis of all surgically treated penile cancer patients managed at our institute from January 2011 to March 2014 was performed. Patient characteristics, histological factors, and lymph node involvement were identified. Logistic regression analysis was used to compute odds ratio (OR) in univariate and multivariate analysis. Ninety seven patients underwent surgical management at our institute during the abovementioned period. Grade III tumor, presence of lymphovascular invasion, tumor thickness >10 mm, perineural invasion (PNI) and Ki67 >50% were significantly associated with nodal metastasis. On multivariate analysis, only presence of PNI was found to be significant (OR: 6.82) (95% confidence interval: 1.72-27.03) (p = 0.006). PNI is a strong independent predictor of occult lymph node metastasis in penile cancers. Its inclusion in stratification of clinically node negative patients will identify high-risk patients who will benefit from prophylactic lymphadenectomy.

Identifiants

pubmed: 34818663
pii: 000519918
doi: 10.1159/000519918
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

716-721

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Kanuj Malik (K)

Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India, malikkanuj03@gmail.com.

Deepak Chandrasekaran (D)

Department of Surgical Oncology, Velammal Medical College Hospital and Research Institute, Madurai, India.

Narayanaswamy Kathiresan (N)

Department of Surgical Oncology, Apollo Speciality Hospital, Chennai, India.

Anand Raja (A)

Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH